中国实用口腔科杂志

• 论著 • 上一篇    下一篇

has-miR-16在舌鳞癌中的生物学功能及分子机制研究

李琦a耿亚军b郭菁a鄂丽华a徐溢涵a,金武龙a    

  1. 内蒙古医科大学附属医院 a 口腔科,b 肝胆外科,内蒙古 呼和浩特  010059
  • 出版日期:2017-06-15 发布日期:2017-07-11
  • 基金资助:

    内蒙古医科大学科技百万工程项目(2014YKDKJBW01);内蒙古医科大学人才团队项目:口腔再生医学团队(NYTD-2015011)

  • Online:2017-06-15 Published:2017-07-11

摘要:

目的    探究has-miR-16在舌鳞癌发生发展中的作用及分子机制。方法    通过实时荧光定量PCR检测36例舌鳞癌与癌旁组织样本中has-miR-16的表达特征,并检测其在舌鳞癌细胞株CAL-27、SCC-9及正常人口腔黏膜成纤维细胞中的表达情况。转染has-miR-16 模拟物(mimics)至CAL-27和SCC-9细胞,采用噻唑蓝(MTT)比色法和创伤愈合试验检测其对细胞增殖及迁移的影响。通过生物信息学方法预测has-miR-16的靶基因,并采用双荧光素酶报告基因试验进行验证。结果    Has-miR-16在舌鳞癌组织的表达量明显低于癌旁组织(P < 0.05),其在CAL-27及SCC-9细胞中的表达量亦低于正常人口腔黏膜成纤维细胞(P < 0.05)。体外功能实验发现,过表达has-miR-16可显著抑制CAL-27与SCC-9细胞的增殖及迁移(P < 0.05)。生物信息学分析及双荧光素酶报告基因试验发现,成髓细胞瘤癌基因(myeloblastosis oncogene,MYB)是has-miR-16的靶基因。结论    has-miR-16在舌鳞癌组织及细胞系中低表达,过表达has-miR-16可抑制舌鳞癌细胞的增殖及迁移。has-miR-16在舌鳞癌中发挥抑癌作用,其作用机制可能通过调控MYB而实现。

关键词:  , has-miR-16, 舌鳞癌, 抑癌作用, 成髓细胞瘤癌基因

Abstract:

Objective    To study the role and molecular mechanism of has-miR-16 in the development of tongue squamous cell carcinoma (TSCC). Methods    The expression of has-miR-16 was detected in 36 cases of TSCC tissues and matched normal tissues by using Quantitative real time PCR. The expression of has-miR-16 in TSCC cells (CAL-27 and SCC-9) and the normal human oral mucosa fibroblast cells (hOMF) was also analyzed by Quantitative real time PCR. The cell proliferation and migration of CAL-27 and SCC-9 were analyzed by MTT and wound healing assays after being transfected with has-miR-16 mimics or mimics control. The target gene of has-miR-16 was predicted by bioinformatics and verified by dual luciferase reporter assay. Results    The expression of has-miR-16 in TSCC tissues was significantly lower than matched normal tissues (P < 0.05). The expression of has-miR-16 was also down-regulated in CAL-27 and SCC-9 cells compared with hOMF cells (P < 0.05). Over-expression of has-miR-16 inhibited cell proliferation and migration in CAL-27 and SCC-9 cells (P < 0.05). MYB (Myeloblastosis oncogene) was the target gene of has-miR-16 in TSCC. Conclusion    Has-miR-16 is down-regulated in TSCC tissue and cell lines;over-expression of has-miR-16 inhibites CAL-27 and SCC-9 cells proliferation and migration;has-miR-16 acts as tumor suppressor in TSCC,which may play its role via regulating MYB.

Key words: has-miR-16;tongue squamous cell carcinoma, TSCC;suppressor;myeloblastosis oncogene, MYB